BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35182736)

  • 1. Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives.
    Huang B; Zhang Y
    Drug Discov Today; 2022 Jul; 27(7):1936-1944. PubMed ID: 35182736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning Natural Products in Drug Discovery.
    Rastelli G; Pellati F; Pinzi L; Gamberini MC
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32143476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
    Roy S; Dhaneshwar S; Bhasin B
    Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing: progress, challenges and recommendations.
    Pushpakom S; Iorio F; Eyers PA; Escott KJ; Hopper S; Wells A; Doig A; Guilliams T; Latimer J; McNamee C; Norris A; Sanseau P; Cavalla D; Pirmohamed M
    Nat Rev Drug Discov; 2019 Jan; 18(1):41-58. PubMed ID: 30310233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning in target prediction and drug repositioning: Recent advances and challenges.
    Yu JL; Dai QQ; Li GB
    Drug Discov Today; 2022 Jul; 27(7):1796-1814. PubMed ID: 34718208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning.
    de Almeida TF; Cunha-Junior EF; Wanderley JLM; Pacheco JDS; Pinto-da-Silva LH; Andrade-Neto VV; Chaves SP
    Front Cell Infect Microbiol; 2024; 14():1384244. PubMed ID: 38544526
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.
    Jin G; Wong ST
    Drug Discov Today; 2014 May; 19(5):637-44. PubMed ID: 24239728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
    Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
    BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-based drug repositioning.
    Wu Z; Wang Y; Chen L
    Mol Biosyst; 2013 Jun; 9(6):1268-81. PubMed ID: 23493874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systems-level analysis of drug-target-disease associations for drug repositioning.
    Rutherford KD; Mazandu GK; Mulder NJ
    Brief Funct Genomics; 2018 Jan; 17(1):34-41. PubMed ID: 28968683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in drug repositioning for the discovery of new anticancer drugs.
    Shim JS; Liu JO
    Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Recent Developments and Progress in Computational Drug Repositioning.
    Shi W; Chen X; Deng L
    Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repositioning: a brief overview.
    Jourdan JP; Bureau R; Rochais C; Dallemagne P
    J Pharm Pharmacol; 2020 Sep; 72(9):1145-1151. PubMed ID: 32301512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Repositioning: A Unique Approach to Refurbish Drug Discovery.
    Kale MA; Shamkuwar PB; Mourya VK; Deshpande AB; Shelke PA
    Curr Drug Discov Technol; 2022; 19(1):e140122192307. PubMed ID: 33726652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
    Padhy BM; Gupta YK
    J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repositioning based on the heterogeneous information fusion graph convolutional network.
    Cai L; Lu C; Xu J; Meng Y; Wang P; Fu X; Zeng X; Su Y
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34378011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing of HDAC inhibitors toward anti-hepatitis C virus drug discovery: teaching an old dog new tricks.
    Zhao F; Liu N; Zhan P; Liu X
    Future Med Chem; 2015; 7(11):1367-71. PubMed ID: 26230876
    [No Abstract]   [Full Text] [Related]  

  • 18. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
    Kwon OS; Kim W; Cha HJ; Lee H
    Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional Neural Matrix Factorization model for computational drug repositioning.
    Yang X; Zamit L; Liu Y; He J
    BMC Bioinformatics; 2019 Aug; 20(1):423. PubMed ID: 31412762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.